EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review

Tao Zhang, Jindong Zhang, Liping Duan

Nutrients · 24.03.2023 · 15 (7) · 1566

DOI: 10.3390/nu15071566 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 24.03.2023. Verfasst von Tao Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colitis, Crohn Disease, Probiotics. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Many preclinical studies have demonstrated the effectiveness of genetically modified probiotics (gm probiotics) in animal models of inflammatory bowel disease (IBD).

Objective

This systematic review was performed to investigate the role of gm probiotics in treating IBD and to clarify the involved mechanisms.

Methods

PubMed, Web of Science, Cochrane Library, and Medline were searched from their inception to 18 September 2022 to identify preclinical and clinical studies exploring the efficacy of gm probiotics in IBD animal models or IBD patients. Two independent researchers extracted data from the included studies, and the data were pooled by the type of study; that is, preclinical or clinical.

Results

Forty-five preclinical studies were included. In these studies, sodium dextran sulfate and trinitrobenzene sulfonic acid were used to induce colitis. Eleven probiotic species have been genetically modified to produce therapeutic substances, including IL-10, antimicrobial peptides, antioxidant enzymes, and short-chain fatty acids, with potential therapeutic properties against colitis. The results showed generally positive effects of gm probiotics in reducing disease activity and ameliorating intestinal damage in IBD models; however, the efficacy of gm probiotics compared to that of wild-type probiotics in many studies was unclear. The main mechanisms identified include modulation of the diversity and composition of the gut microbiota, production of regulatory metabolites by beneficial bacteria, reduction of the pro- to anti-inflammatory cytokine ratio in colonic tissue and plasma, modulation of oxidative stress activity in the colon, and improvement of intestinal barrier integrity. Moreover, only one clinical trial with 10 patients with Crohn’s disease was included, which showed that L. lactis producing IL-10 was safe, and a decrease in disease activity was observed in these patients.

Conclusions

Gm probiotics have a certain efficacy in colitis models through several mechanisms. However, given the scarcity of clinical trials, it is important for researchers to pay more attention to gm probiotics that are more effective and safer than wild-type probiotics to facilitate further clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesColitisCrohn DiseaseProbioticsAnimalsInterleukin-10Disease Models, Animal

Stichwörter der Autor:innen

colitisefficacygenetically modified probioticsinflammatory bowel disease

Substanzen

Interleukin-10

Autor:innen und Institutionen

  • Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China.

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • National Key R&D Program of China

Zitieren

APA

Zhang, T., Zhang, J., & Duan, L. (2023). The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review. Nutrients, 15(7), 1566. https://doi.org/10.3390/nu15071566

Vancouver

Zhang T, Zhang J, Duan L. The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review. Nutrients. 2023;15(7):1566. doi:10.3390/nu15071566

BibTeX
@article{Zhang2023,
  author = {Zhang, Tao and Zhang, Jindong and Duan, Liping},
  title = {The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {7},
  pages = {1566},
  doi = {10.3390/nu15071566}
}
Kostenlos starten →